首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >The role of adoptivley transferred CD8 T cells and host cells in the control of the groth of the EG7 thymoma:factors that determine therelative effectiveness and homing properties of Tc1 and Tc2 effectors
【24h】

The role of adoptivley transferred CD8 T cells and host cells in the control of the groth of the EG7 thymoma:factors that determine therelative effectiveness and homing properties of Tc1 and Tc2 effectors

机译:传代转移的CD8 T细胞和宿主细胞在EG7胸腺瘤的控制中的作用:决定Tc1和Tc2效应子相对有效性和归巢特性的因素

获取原文
获取原文并翻译 | 示例
           

摘要

We had previously examined the factors that regulate the response of OVA-specific TCR-transgenic CD8 T cells to the B16 OVA melanoma, growing as lung metastases. We examine here whether the same parameters operate for EG7, growing intradermally. Tcl or Tc2 CD8 effector cells from OT-1 mice were injected either mixed with the tumor or i.v. at day 0 or 7. Tc2 were one-fifth to one-tenth as effective as Tcl when injected with the tumor, in controlling tumor growth, but were only 1/20 to 1/100 injected i.v. Tcl injected i.v. entered the draining lymph nodes faster than Tc2 and caused a faster accumulation of host cells. Both caused an abrupt termination of host cell entry into lymph nodes and spleen after tumor elimination, but this occurred earlier for Tcl than for Tc2. Host responses were ineffective in the absence of adoptive transfer but were essential after transfer. Perform expression in the donor cells plays no role in adoptively transferred Tcl or Tc2 control of the tumor, and neither IL-4 nor 1L5 is needed for Tcl or Tc2 function. Tcl cells from mice lacking IFN-’y, however, control tumor growth less well, whereas Tc2 effectors lacking IFN-’y are unaffected. Tcl from IFN-y-deficient mice attract fewer host cells to the draining lymph node, whereas Tcl cells from perform-deficient donors are unimpaired. We conclude that host cell recruitment is a crucial element in adoptive immunotherapy. The differences between the EG7 and the previous B16 melanoma model are discussed.
机译:我们之前已经检查了调节OVA特异性TCR转基因CD8 T细胞对B16 OVA黑色素瘤(随着肺转移而生长)的应答的因素。我们在这里检查是否有相同的参数适用于皮内生长的EG7。将来自OT-1小鼠的Tcl或Tc2 CD8效应细胞与肿瘤混合或静脉内注射。在第0天或第7天,在控制肿瘤生长方面,Tc2的有效性是Tcl的五分之一至十分之一。在静脉注射中,Tc2的有效性仅为Tcl的1/20至1/100。 Tcl静脉注射比Tc2更快地进入引流淋巴结,并导致宿主细胞更快积累。两者均导致肿瘤消除后宿主细胞突然终止进入淋巴结和脾脏,但是Tcl的发生要早于Tc2。在没有过继转移的情况下,寄主的反应无效,但在转移后是至关重要的。在供体细胞中进行表达在肿瘤的过继转移的Tcl或Tc2控制中不起作用,并且Tcl或Tc2功能不需要IL-4或1L5。来自缺乏IFN-γ的小鼠的Tcl细胞不能很好地控制肿瘤的生长,而缺乏IFN-γ的Tc2效应子不受影响。来自IFN-y缺陷小鼠的Tcl吸引较少的宿主细胞至引流淋巴结,而来自功能缺陷供体的Tcl细胞未受损。我们得出结论,宿主细胞募集是过继免疫疗法中的关键要素。讨论了EG7和以前的B16黑色素瘤模型之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号